Professor Lyu is a world-leading scientist in aptamer-based translational medicine and drug discovery. He is not only working on basic research that demonstrates novel precision medicine-based therapeutic strategies for rheumatic disease treatment, but also on translational research in collaboration with pharmaceutical industry for the ...

Professor Lyu Aiping, a world-leading scientist in aptamer-based translational medicine and drug discovery, is currently Vice-President (Research and Development). Prof Lyu is the Dr. Kennedy Y. H. Wong Endowed Professor in Chinese Medicine at HKBU.

吕爱平教授是适配子转化医学及药物研发领域的世界顶尖科学家，现任浸大副校长（研究及拓展）。 吕教授现为浸大黄英豪博士中医药教授，于2022年获欧洲科学院选为外籍院士，以表扬他在系统医学方面多年来的卓越学术成就。 作为副校长（研究及拓展），吕教授负责领导大学的整体研究策略、研究拨款策略、研究基础设施和研究生教育的发展及推动多学科和跨学科研究、和领导研究团队争取参与校外的大型研究项目。 吕教授于1983年在江西中医药大学取得中医药学士学 …

Jun 13, 2023 · The Council of Hong Kong Baptist University (HKBU) approved today (13 June) the appointment of Professor Lyu Aiping as Vice-President (Research and Development), with effect from 1 August 2023. Professor Lyu is a world-leading scientist in aptamer-based translational medicine and drug discovery.

Prof Lyu has published more than 30 books and over 500 articles, including 350 articles in SCI journals such as Nature Medicine, Nature Communication, Biomaterials, Briefings in Bioinformatics, Journal of Proteomic Research.

Professor Lyu Aiping is Chair Professor & Dean of School of Chinese Medicine, Hong Kong Baptist University, Director of Institute for Advancing Translational Medicine in Bone & Joint Diseases (TMBJ) of HKBU, Director of Institute of Integrated Bioinformedicine & Translational Science (IBTS) of HKBU, Chair Professor in CACMS and Recipient of the ...

Nov 25, 2021 · 吕爱平，讲座教授，上海市中医药研究院关节炎研究所所长、名誉所长，香港浸会大学中医药学院院长. 通讯地址：香港九龙塘，香港浸会大学中医药学院. Aiping Lv, Chair professor, Honorary Director of Arthritis Research Institute, Shanghai Academy of Traditional...

May 25, 2022 · The therapeutic aptamer drug targeting sclerostin loop3 developed by Professor Lyu in collaboration with Aptacure has been granted Orphan Drug Designation (DRU-2019-6966) by the US FDA for the treatment of osteogenesis imperfecta.

Professor Lyu Aiping is Chair Professor & Dean of School of Chinese Medicine, Hong Kong Baptist University, Director of Institute for Advancing Translational Medicine in Bone &...

Apr 2, 2025 · This week, Prof. Guan Daogang, a distinguished professor and doctoral supervisor, along with his research team, visited Prof. Lyu Aiping. The meeting aimed to foster collaboration and exchange innovative ideas between their respective research groups.